N-(2-Ethoxybenzyl)tryptamine
 
N-[(2-Ethoxyphenyl)methyl]-2-(1H-indol-3-yl)ethan-1-amine
N-(2-Ethoxybenzyl)-2-(1H-indol-3-yl)ethan-1-amine
 5558 ·  C19H22N2O ·  294.391
 InChI=1S/C19H22N2O/c1-2-22-19-10-6-3-7-16(19)13-20-12-11-15-14-21-18-9-5-4-8-17(15)18/h3-10,14,20-21H,2,11-13H2,1H3
 HDVBXBQHKIFIPF-UHFFFAOYSA-N This stereoisomer Any stereoisomer
 CCOc1ccccc1CNCCc1c[nH]c2c1cccc2

Heim, R. Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure. SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. 3.9 MB. In German.

Silva, ME; Heim, R; Strasser, A; Elz, S; Dove, S. Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor. J. Comput. Aided Mol. Des., 1 Jan 2011, 25 (1), 51–66. 834 kB. https://doi.org/10.1007/s10822-010-9400-2

Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5.9 MB.

T-NEPOMe
5MT-NB4Me
5-MeO-2-Ph-DMT
1-Bz-5-MeO-AMT
5657
5838
5831
5830
5825
5824
5815
5814
5813
5MT-NB3Me
5-BnO-DMT
1-Benzylpsilocin
13 November 2018 · Creative Commons BY-NC-SA ·